{"abstract": "Carl C. Icahn has withdrawn his lawsuit against Amylin Pharmaceuticals, citing a conversation he had with the drug maker\u2019s chief executive. What exactly was said, however, remains a mystery.", "web_url": "https://dealbook.nytimes.com/2012/04/25/amylin-and-icahn-make-nice-sending-shares-up/", "snippet": "Carl C. Icahn has withdrawn his lawsuit against Amylin Pharmaceuticals, citing a conversation he had with the drug maker\u2019s chief executive. What exactly was said, however, remains a mystery.", "lead_paragraph": "The activist investor Carl C. Icahn has withdrawn his lawsuit against Amylin Pharmaceuticals, helping propel the diabetes drug maker\u2019s shares up more than 3.5 percent.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amylin and Icahn Make Nice, Sending Shares Up", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "persons", "value": "Icahn, Carl C", "rank": 2, "major": "N"}, {"name": "organizations", "value": "AMYLIN PHARMACEUTICALS INC", "rank": 3, "major": "N"}], "pub_date": "2012-04-25T19:05:20+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Michael J. de la Merced", "person": [{"firstname": "Michael", "middlename": "J.", "lastname": "de la Merced", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/fb152281-ed46-5670-8521-e4ab84d15294", "word_count": 356, "uri": "nyt://article/fb152281-ed46-5670-8521-e4ab84d15294"}